Recurrent Soft Tissue Sarcoma Active Not Recruiting Phase 2 Trials for Cabozantinib (DB08875)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0105100 (Recurrent Soft Tissue Sarcoma) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02867592 | Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors | Treatment |